tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

3D Medicines Inc. Schedules Board Meeting for Interim Results and Dividend Consideration

Story Highlights
3D Medicines Inc. Schedules Board Meeting for Interim Results and Dividend Consideration

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

3D Medicines, Inc. ( (HK:1244) ) has provided an update.

3D Medicines Inc. has announced that its board of directors will meet on August 29, 2025, to approve the unaudited interim results for the first half of the year and discuss the potential payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and investor relations.

More about 3D Medicines, Inc.

Average Trading Volume: 538,358

Technical Sentiment Signal: Buy

Current Market Cap: HK$2.15B

Find detailed analytics on 1244 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1